Selecta Biosciences, Inc.

Selecta Biosciences, Inc.verified

SELB

Price:

$0.8812

Market Cap:

$135.20M

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies c...[Read more]

Industry

Biotechnology

IPO Date

2016-06-22

Stock Exchange

NASDAQ

Ticker

SELB

The Enterprise Value as of December 2024 (TTM) for Selecta Biosciences, Inc. (SELB) is 69.24M

According to Selecta Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 69.24M. This represents a change of 11.36% compared to the average of 62.18M of the last 4 quarters.

Selecta Biosciences, Inc. (SELB) Historical Enterprise Value (quarterly & annually)

How has SELB Enterprise Value performed in the past?

The mean historical Enterprise Value of Selecta Biosciences, Inc. over the last ten years is 10.47B. The current 69.24M Enterprise Value has changed -33.88% with respect to the historical average. Over the past ten years (40 quarters), SELB's Enterprise Value was at its highest in in the March 2021 quarter at 411.06M. The Enterprise Value was at its lowest in in the December 2023 quarter at -65956000.00.

Quarterly (TTM)
Annual

Average

10.47B

Median

155.23M

Minimum

37.79M

Maximum

103.44B

Selecta Biosciences, Inc. (SELB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Selecta Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Enterprise Value = 103.44B

Minimum Annual Increase = -71.13%

Minimum Annual Enterprise Value = 37.79M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023103.44B108.71%
202295.06M-67.66%
2021293.94M44.58%
2020203.31M438.00%
201937.79M-13.20%
201843.54M-71.13%
2017150.79M13.07%
2016133.36M-16.48%
2015159.68M-6.60%
2014170.97MInfinity%

Selecta Biosciences, Inc. (SELB) Average Enterprise Value

How has SELB Enterprise Value performed in the past?

The current Enterprise Value of Selecta Biosciences, Inc. (SELB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

34.61B

5-year avg

20.81B

10-year avg

10.47B

Selecta Biosciences, Inc. (SELB) Enterprise Value vs. Peers

How is SELB’s Enterprise Value compared to its peers?

Selecta Biosciences, Inc.’s Enterprise Value is less than Paratek Pharmaceuticals, Inc. (351.99M), less than Corvus Pharmaceuticals, Inc. (305.71M), less than Immutep Limited (365.43M), less than Icosavax, Inc. (713.87M), less than Checkpoint Therapeutics, Inc. (168.52M), greater than Mustang Bio, Inc. (5.73M), less than Reviva Pharmaceuticals Holdings, Inc. (75.80M), greater than Fortress Biotech, Inc. (61.81M), less than Kodiak Sciences Inc. (388.92M), less than Reviva Pharmaceuticals Holdings, Inc. (75.80M), greater than Eyenovia, Inc. (15.24M), greater than Cognition Therapeutics, Inc. (4.32M), greater than TransCode Therapeutics, Inc. (629.89K), greater than Gamida Cell Ltd. (57.65M), less than Rigel Pharmaceuticals, Inc. (288.00M), less than Geron Corporation (1.97B), less than ImmunoGen, Inc. (8.19B), greater than Cidara Therapeutics, Inc. (38.84M), greater than Fortress Biotech, Inc. (61.81M),

Build a custom stock screener for Selecta Biosciences, Inc. (SELB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Selecta Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Selecta Biosciences, Inc. (SELB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Selecta Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Selecta Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Selecta Biosciences, Inc. (SELB)?

What is the 3-year average Enterprise Value for Selecta Biosciences, Inc. (SELB)?

What is the 5-year average Enterprise Value for Selecta Biosciences, Inc. (SELB)?

How does the current Enterprise Value for Selecta Biosciences, Inc. (SELB) compare to its historical average?